体内CAR-Tin vivo CAR-T

体内重编程T细胞

每条都摘自下方编号的来源原文;只写事实,不写预测或建议。

技术简介

  • 传统体外CAR-T需采集患者细胞、在体外改造,再回输患者。1
    Marketed CAR-T cell cancer therapies such as Johnson & Johnson’s Carvykti use an “ex vivo” process that involves harvesting a patient’s cells, modifying them and infusing them back into the body.

来源

  1. biopharmadive.com · Pfizer leaps into ‘in vivo’ CAR-T with latest China deal | BioPharma Dive · 2026-11-18